Neurocognitive safety after 96-wks on ATV/r+3TC: Results of the randomized salt trial

Category Primary study
JournalTopics in Antiviral Medicine
Year 2016
This article has no abstract
Epistemonikos ID: a98fdc3e55662249094eb2e1d7af6c4a94de3ffd
First added on: Feb 08, 2025